Vir Biotechnology, Inc. (VIR)
USD 5.26
(-5.82%)
USD 5.26
(-5.82%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -684.3 Million USD | -167.95% |
| 2022 | 833.06 Million USD | 233.99% |
| 2021 | 420.75 Million USD | 195.19% |
| 2020 | -289.79 Million USD | -66.86% |
| 2019 | -173.46 Million USD | -53.51% |
| 2018 | -115.93 Million USD | -43.02% |
| 2017 | -81.06 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -125.1 Million USD | -69.52% |
| 2024 Q3 | -213.54 Million USD | -68.39% |
| 2024 Q1 | -47.96 Million USD | 43.83% |
| 2023 Q2 | -210.1 Million USD | -61.28% |
| 2023 FY | - USD | -167.95% |
| 2023 Q4 | -112.63 Million USD | 38.79% |
| 2023 Q3 | -184.02 Million USD | 12.41% |
| 2023 Q1 | -130.26 Million USD | 18.27% |
| 2022 Q3 | 208.55 Million USD | 198.27% |
| 2022 Q2 | -212.23 Million USD | -119.11% |
| 2022 Q1 | 1.11 Billion USD | 85.76% |
| 2022 FY | - USD | 233.99% |
| 2022 Q4 | -159.38 Million USD | -176.42% |
| 2021 FY | - USD | 195.19% |
| 2021 Q4 | 597.77 Million USD | 376.78% |
| 2021 Q3 | -215.97 Million USD | -446.0% |
| 2021 Q2 | 62.41 Million USD | 139.7% |
| 2021 Q1 | -157.23 Million USD | -45.04% |
| 2020 Q3 | -87.61 Million USD | -216.48% |
| 2020 Q2 | -27.68 Million USD | 60.79% |
| 2020 FY | - USD | -66.86% |
| 2020 Q1 | -70.6 Million USD | -10.74% |
| 2020 Q4 | -108.4 Million USD | -23.73% |
| 2019 Q3 | -46.47 Million USD | -34.17% |
| 2019 FY | - USD | -53.51% |
| 2019 Q1 | -29.75 Million USD | -14.9% |
| 2019 Q4 | -63.75 Million USD | -37.2% |
| 2019 Q2 | -34.63 Million USD | -16.39% |
| 2018 Q4 | -25.89 Million USD | 22.93% |
| 2018 Q1 | -27.45 Million USD | 0.0% |
| 2018 FY | - USD | -43.02% |
| 2018 Q2 | -27.45 Million USD | 0.0% |
| 2018 Q3 | -33.6 Million USD | -22.41% |
| 2017 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| AbCellera Biologics Inc. | -192.15 Million USD | -256.116% |
| Alkermes plc | 495.04 Million USD | 238.23% |
| Agenus Inc. | -145.92 Million USD | -368.946% |
| Aptorum Group Limited | -9.59 Million USD | -7028.922% |
| Ardelyx, Inc. | -55.35 Million USD | -1136.234% |
| Dyadic International, Inc. | -8.22 Million USD | -8215.027% |
| Eton Pharmaceuticals, Inc. | -291 Thousand USD | -235056.357% |
| Lantern Pharma Inc. | -15.78 Million USD | -4234.696% |
| Inhibikase Therapeutics, Inc. | -19.91 Million USD | -3336.578% |
| Novavax, Inc. | -487.39 Million USD | -40.402% |
| Janux Therapeutics, Inc. | -71.02 Million USD | -863.484% |
| Pyxis Oncology, Inc. | -78.49 Million USD | -771.804% |
| TransCode Therapeutics, Inc. | -17.97 Million USD | -3707.31% |
| Ocuphire Pharma, Inc. | -9.96 Million USD | -6765.018% |
| Outlook Therapeutics, Inc. | -57.37 Million USD | -1092.669% |
| Madrigal Pharmaceuticals, Inc. | -379.96 Million USD | -80.095% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -2738.039% |
| SELLAS Life Sciences Group, Inc. | 529 Thousand USD | 129458.223% |
| Syros Pharmaceuticals, Inc. | -157.19 Million USD | -335.322% |
| Barinthus Biotherapeutics plc | -74.81 Million USD | -814.664% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | -3294.538% |
| Xeris Biopharma Holdings, Inc. | -23.73 Million USD | -2783.105% |
| Clearside Biomedical, Inc. | -23.05 Million USD | -2867.755% |
| C4 Therapeutics, Inc. | -122.1 Million USD | -460.433% |
| Alnylam Pharmaceuticals, Inc. | -258.24 Million USD | -164.986% |
| AlloVir, Inc. | -190.14 Million USD | -259.884% |
| Arrowhead Pharmaceuticals, Inc. | -175.67 Million USD | -289.536% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -2238.865% |
| Bicycle Therapeutics plc | -183.4 Million USD | -273.122% |
| BioXcel Therapeutics, Inc. | -165.42 Million USD | -313.675% |
| ChromaDex Corporation | -3.89 Million USD | -17473.318% |
| Chimerix, Inc. | -92.97 Million USD | -636.018% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.43 Million USD | -1439.955% |
| Caribou Biosciences, Inc. | -112.53 Million USD | -508.087% |
| CRISPR Therapeutics AG | -202.7 Million USD | -237.593% |
| Precision BioSciences, Inc. | -32.04 Million USD | -2035.65% |
| Fate Therapeutics, Inc. | -172.22 Million USD | -297.323% |
| Fortress Biotech, Inc. | -133.64 Million USD | -412.04% |
| Fortress Biotech, Inc. | -133.64 Million USD | -412.04% |
| HOOKIPA Pharma Inc. | -77.34 Million USD | -784.767% |
| ImmuCell Corporation | -2.5 Million USD | -27227.634% |
| IDEAYA Biosciences, Inc. | -130.42 Million USD | -424.689% |
| Immix Biopharma, Inc. | -16.13 Million USD | -4140.952% |
| Incyte Corporation | 919.42 Million USD | 174.427% |
| Innoviva, Inc. | 248.96 Million USD | 374.865% |
| IO Biotech, Inc. | -91.22 Million USD | -650.104% |
| Jaguar Health, Inc. | -33.13 Million USD | -1965.452% |
| Keros Therapeutics, Inc. | -152.17 Million USD | -349.677% |
| Ligand Pharmaceuticals Incorporated | 101.72 Million USD | 772.688% |
| ContextLogic Inc. | -324 Million USD | -111.205% |
| MiMedx Group, Inc. | 40.51 Million USD | 1788.933% |
| MEI Pharma, Inc. | 26.38 Million USD | 2694.03% |
| NextCure, Inc. | -59.03 Million USD | -1059.073% |
| Onconetix, Inc. | -36.7 Million USD | -1764.25% |
| Oncternal Therapeutics, Inc. | 2.23 Million USD | 30717.673% |
| Opthea Limited | -200.01 Million USD | -242.12% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -24769.53% |
| Vaxcyte, Inc. | -464.88 Million USD | -47.199% |
| PDS Biotechnology Corporation | -40.08 Million USD | -1607.136% |
| Precigen, Inc. | -89.22 Million USD | -666.935% |
| Pharming Group N.V. | 9.87 Million USD | 7028.268% |
| Phathom Pharmaceuticals, Inc. | -159.04 Million USD | -330.248% |
| Pieris Pharmaceuticals, Inc. | -22.76 Million USD | -2906.348% |
| PureTech Health plc | -11.62 Million USD | -5785.482% |
| Rigel Pharmaceuticals, Inc. | -16.98 Million USD | -3929.827% |
| Avidity Biosciences, Inc. | -233.49 Million USD | -193.068% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -2738.039% |
| Sangamo Therapeutics, Inc. | -87.42 Million USD | -682.716% |
| Sol-Gel Technologies Ltd. | -28.96 Million USD | -2262.687% |
| Acelyrin, Inc. | -381.52 Million USD | -79.36% |
| Salarius Pharmaceuticals, Inc. | -12.88 Thousand USD | -5310810.687% |
| Summit Therapeutics Inc. | 1 Million USD | 68462.138% |
| Sensei Biotherapeutics, Inc. | -33.38 Million USD | -1949.677% |
| Senti Biosciences, Inc. | -61.33 Million USD | -1015.666% |
| Stoke Therapeutics, Inc. | -112.3 Million USD | -509.333% |
| Elevation Oncology, Inc. | -41.46 Million USD | -1550.24% |
| Alaunos Therapeutics, Inc. | -30.9 Million USD | -2114.293% |
| Telomir Pharmaceuticals, Inc. Common Stock | -6.11 Million USD | -11087.768% |
| Entrada Therapeutics, Inc. | -321 Thousand USD | -213079.128% |
| VistaGen Therapeutics, Inc. | -32.45 Million USD | -2008.603% |
| Kintara Therapeutics, Inc. | -8.39 Million USD | -8050.369% |
| Wave Life Sciences Ltd. | -58.79 Million USD | -1063.982% |
| Seer, Inc. | -97.88 Million USD | -599.091% |
| Verrica Pharmaceuticals Inc. | -62.19 Million USD | -1000.222% |
| Aadi Bioscience, Inc. | -65.36 Million USD | -946.898% |
| ESSA Pharma Inc. | -26.45 Million USD | -2486.645% |
| GlycoMimetics, Inc. | -39.12 Million USD | -1649.157% |
| GT Biopharma, Inc. | 5.97 Million USD | 11545.141% |
| Inhibrx Biosciences, Inc. | -206.69 Million USD | -231.073% |
| Akebia Therapeutics, Inc. | -6.86 Million USD | -9863.672% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 888.261% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -1105.739% |
| Orchestra BioMed Holdings, Inc. | -51.21 Million USD | -1236.037% |
| Alzamend Neuro, Inc. | -9.88 Million USD | -6821.327% |
| Sorrento Therapeutics, Inc. | -539.92 Million USD | -26.74% |
| TRACON Pharmaceuticals, Inc. | -6.88 Million USD | -9840.514% |
| Viracta Therapeutics, Inc. | -46.86 Million USD | -1360.256% |
| Rocket Pharmaceuticals, Inc. | -236.62 Million USD | -189.198% |
| Aptose Biosciences Inc. | -52.26 Million USD | -1209.224% |
| ZyVersa Therapeutics, Inc. | -107.74 Million USD | -535.125% |
| Soligenix, Inc. | -7.85 Million USD | -8614.097% |
| Century Therapeutics, Inc. | -121.2 Million USD | -464.571% |
| Kura Oncology, Inc. | -164.95 Million USD | -314.843% |
| TScan Therapeutics, Inc. | -80.09 Million USD | -754.335% |
| Intensity Therapeutics, Inc. | -10.08 Million USD | -6684.702% |
| Ocean Biomedical, Inc. | -957.73 Thousand USD | -71350.051% |
| CytomX Therapeutics, Inc. | -4.3 Million USD | -15780.831% |
| Autolus Therapeutics plc | -156.77 Million USD | -336.503% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -708.327% |
| EyePoint Pharmaceuticals, Inc. | -69 Million USD | -891.732% |
| Eterna Therapeutics Inc. | -19.93 Million USD | -3332.853% |
| Adaptive Biotechnologies Corporation | -189.27 Million USD | -261.544% |
| GRI Bio, Inc. | -10.89 Million USD | -6179.18% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -15053.857% |
| Tenaya Therapeutics, Inc. | -122.5 Million USD | -458.589% |
| IGM Biosciences, Inc. | -253.35 Million USD | -170.094% |
| INmune Bio, Inc. | - USD | Infinity% |
| Heron Therapeutics, Inc. | -103.79 Million USD | -559.304% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -1694.511% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -4363.565% |
| Entero Therapeutics, Inc. | -15.74 Million USD | -4246.659% |
| Milestone Pharmaceuticals Inc. | -56.84 Million USD | -1103.809% |
| X4 Pharmaceuticals, Inc. | -107.1 Million USD | -538.922% |
| Atara Biotherapeutics, Inc. | -265.99 Million USD | -157.26% |
| Coherus BioSciences, Inc. | -193.93 Million USD | -252.845% |
| Verastem, Inc. | -83.16 Million USD | -722.818% |
| Abeona Therapeutics Inc. | -50.57 Million USD | -1253.13% |
| Pliant Therapeutics, Inc. | -158.22 Million USD | -332.48% |
| Tonix Pharmaceuticals Holding Corp. | -114.08 Million USD | -499.799% |
| Histogen Inc. | -10.5 Million USD | -6415.329% |
| Aprea Therapeutics, Inc. | -14.27 Million USD | -4692.15% |
| Surrozen, Inc. | -41.13 Million USD | -1563.721% |
| Organovo Holdings, Inc. | -14.8 Million USD | -4521.809% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 21337954.693% |
| Ovid Therapeutics Inc. | -58.71 Million USD | -1065.505% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | -1234.084% |
| CASI Pharmaceuticals, Inc. | -21.53 Million USD | -3077.051% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.33 Million USD | -8107.059% |
| Centessa Pharmaceuticals plc | -166.06 Million USD | -312.068% |
| Hepion Pharmaceuticals, Inc. | -49.25 Million USD | -1289.213% |
| Arcturus Therapeutics Holdings Inc. | -24.16 Million USD | -2731.685% |
| BioRestorative Therapies, Inc. | -15.05 Million USD | -4445.355% |
| Apollomics, Inc. | -171.74 Million USD | -298.438% |
| Amarin Corporation plc | -50.9 Million USD | -1244.37% |
| Mesoblast Limited | -61.33 Million USD | -1015.757% |
| Turnstone Biologics Corp. | -56.23 Million USD | -1116.888% |
| Kymera Therapeutics, Inc. | -143.2 Million USD | -377.863% |
| Synaptogenix, Inc. | -8.3 Million USD | -8137.188% |
| Tiziana Life Sciences Ltd | -15.33 Million USD | -4361.21% |
| Aurinia Pharmaceuticals Inc. | -63.04 Million USD | -985.389% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -14181.746% |
| Monopar Therapeutics Inc. | 429.03 Thousand USD | 159597.155% |
| Exelixis, Inc. | 196.6 Million USD | 448.066% |
| Better Therapeutics, Inc. | -38.26 Million USD | -1688.472% |
| Nurix Therapeutics, Inc. | -141.4 Million USD | -383.919% |
| Apellis Pharmaceuticals, Inc. | -495.21 Million USD | -38.185% |
| NLS Pharmaceutics AG | -11.79 Million USD | -5701.331% |
| Dermata Therapeutics, Inc. | 247.21 Thousand USD | 276904.495% |
| Aridis Pharmaceuticals, Inc. | -29.5 Million USD | -2219.206% |
| Gritstone bio, Inc. | -126.86 Million USD | -439.405% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -953.02% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -17007.856% |
| Avid Bioservices, Inc. | -11.48 Million USD | -5860.326% |
| Insmed Incorporated | -654.73 Million USD | -4.516% |
| Virpax Pharmaceuticals, Inc. | -2.24 Million USD | -30317.354% |
| MediWound Ltd. | -4.89 Million USD | -13885.387% |
| OmniAb, Inc. | -49.73 Million USD | -1276.013% |
| Alector, Inc. | -142.89 Million USD | -378.897% |
| Seres Therapeutics, Inc. | -85.43 Million USD | -700.975% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -1212.236% |
| Zai Lab Limited | -366.57 Million USD | -86.676% |
| Revance Therapeutics, Inc. | -290.63 Million USD | -135.45% |
| Aura Biosciences, Inc. | -83.69 Million USD | -717.608% |
| Lyell Immunopharma, Inc. | -225.24 Million USD | -203.799% |
| Immunic, Inc. | -99.11 Million USD | -590.436% |
| Tarsus Pharmaceuticals, Inc. | -131.67 Million USD | -419.712% |
| Veracyte, Inc. | -49.4 Million USD | -1284.98% |
| InMed Pharmaceuticals Inc. | -7.06 Million USD | -9587.311% |
| FibroGen, Inc. | -261.4 Million USD | -161.78% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -6042.222% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -9673.931% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.71 Million USD | -3556.087% |
| Jazz Pharmaceuticals plc | 1.44 Billion USD | 147.212% |
| Cyclacel Pharmaceuticals, Inc. | -25.42 Million USD | -2591.783% |
| Amylyx Pharmaceuticals, Inc. | 39.89 Million USD | 1815.48% |
| TG Therapeutics, Inc. | 26.1 Million USD | 2721.858% |
| Galecto, Inc. | -37.51 Million USD | -1723.889% |
| Calithera Biosciences, Inc. | -38.26 Million USD | -1688.331% |
| Fortrea Holdings Inc. | 167.3 Million USD | 509.029% |
| KalVista Pharmaceuticals, Inc. | -134.28 Million USD | -409.611% |
| Aptevo Therapeutics Inc. | -28.31 Million USD | -2317.099% |
| XBiotech Inc. | -35.76 Million USD | -1813.284% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -953.02% |
| Lyra Therapeutics, Inc. | -65.25 Million USD | -948.743% |
| Foghorn Therapeutics Inc. | -104.45 Million USD | -555.119% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -2565.569% |
| Theravance Biopharma, Inc. | -40.86 Million USD | -1574.468% |
| Ultragenyx Pharmaceutical Inc. | -516.45 Million USD | -32.501% |
| Metagenomi, Inc. Common Stock | -56.02 Million USD | -1121.515% |
| Vaxxinity, Inc. | -56.05 Thousand USD | -1220761.358% |
| BioCryst Pharmaceuticals, Inc. | -116.33 Million USD | -488.219% |
| Gain Therapeutics, Inc. | -22.16 Million USD | -2986.688% |
| Cartesian Therapeutics, Inc. | -235.06 Million USD | -191.114% |
| NexImmune, Inc. | -28.16 Million USD | -2329.412% |
| Creative Medical Technology Holdings, Inc. | -5.52 Million USD | -12284.383% |
| Marker Therapeutics, Inc. | -11.79 Million USD | -5702.995% |
| Regeneron Pharmaceuticals, Inc. | 4.65 Billion USD | 114.703% |
| Chemomab Therapeutics Ltd. | -25.39 Million USD | -2594.963% |
| Scopus BioPharma Inc. | -11.71 Million USD | -5742.195% |
| RAPT Therapeutics, Inc. | -125.84 Million USD | -443.764% |
| Ainos, Inc. | -8.77 Million USD | -7700.038% |
| Pluri Inc. | -20.22 Million USD | -3283.461% |
| Prothena Corporation plc | -190.1 Million USD | -259.956% |
| Adaptimmune Therapeutics plc | -128.19 Million USD | -433.788% |
| Celularity Inc. | -183.94 Million USD | -272.014% |
| Rallybio Corporation | -72.37 Million USD | -845.525% |
| Cue Biopharma, Inc. | -46.05 Million USD | -1385.94% |
| MeiraGTx Holdings plc | -57.05 Million USD | -1099.441% |
| Omeros Corporation | -163.61 Million USD | -318.254% |
| Humacyte, Inc. | -96.45 Million USD | -609.433% |
| Immunocore Holdings plc | -59.64 Million USD | -1047.22% |
| Cocrystal Pharma, Inc. | -19.37 Million USD | -3432.444% |
| Cidara Therapeutics, Inc. | -24.36 Million USD | -2708.557% |
| Blueprint Medicines Corporation | -474.61 Million USD | -44.182% |
| CalciMedica, Inc. | -34.18 Million USD | -1901.536% |
| Cabaletta Bio, Inc. | -73.23 Million USD | -834.409% |
| Marinus Pharmaceuticals, Inc. | -125.49 Million USD | -445.276% |
| Scholar Rock Holding Corporation | -168.45 Million USD | -306.234% |
| Sana Biotechnology, Inc. | -252.39 Million USD | -171.13% |
| Pulmatrix, Inc. | -12.64 Million USD | -5311.237% |
| Elicio Therapeutics, Inc. | -32.96 Million USD | -1975.79% |
| Vigil Neuroscience, Inc. | -88.46 Million USD | -673.514% |
| Intellia Therapeutics, Inc. | -506.31 Million USD | -35.154% |
| Adlai Nortye Ltd. American Depositary Shares | -101.21 Million USD | -576.091% |
| Cytokinetics, Incorporated | -456.68 Million USD | -49.842% |
| Eloxx Pharmaceuticals, Inc. | -33.37 Million USD | -1950.475% |
| Nutriband Inc. | -5.12 Million USD | -13260.695% |
| Protara Therapeutics, Inc. | -43.27 Million USD | -1481.404% |
| Vor Biopharma Inc. | -114.37 Million USD | -498.32% |
| Roivant Sciences Ltd. | -996.51 Million USD | 31.33% |
| Evogene Ltd. | -23.2 Million USD | -2849.082% |
| ProKidney Corp. | -147.66 Million USD | -363.405% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -960.363% |
| Hoth Therapeutics, Inc. | -153.14 Thousand USD | -446723.029% |
| BridgeBio Pharma, Inc. | -565.46 Million USD | -21.016% |
| CorMedix Inc. | -48.88 Million USD | -1299.768% |
| BioLineRx Ltd. | -57.06 Million USD | -1099.252% |
| Tango Therapeutics, Inc. | -111.75 Million USD | -512.31% |
| Galectin Therapeutics Inc. | -202 Thousand USD | -338664.851% |
| Atai Life Sciences N.V. | -36.31 Million USD | -1784.567% |
| Renovaro Biosciences Inc. | -79.51 Million USD | -760.577% |
| Aerovate Therapeutics, Inc. | -81.31 Million USD | -741.569% |
| Zentalis Pharmaceuticals, Inc. | -275.5 Million USD | -148.384% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -2126.106% |
| MediciNova, Inc. | -9.87 Million USD | -6826.185% |
| Praxis Precision Medicines, Inc. | -125.94 Million USD | -443.354% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -44619.942% |
| GeoVax Labs, Inc. | -26.66 Million USD | -2465.941% |
| Axsome Therapeutics, Inc. | -224.99 Million USD | -204.148% |
| Biomea Fusion, Inc. | -124.62 Million USD | -449.113% |
| PTC Therapeutics, Inc. | -330.34 Million USD | -107.152% |
| Mereo BioPharma Group plc | -26.05 Million USD | -2526.286% |
| Cullinan Oncology, Inc. | -190.33 Million USD | -259.519% |
| Syndax Pharmaceuticals, Inc. | -229.94 Million USD | -197.599% |
| Absci Corporation | -95.45 Million USD | -616.873% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -2179.117% |
| 4D Molecular Therapeutics, Inc. | -107.11 Million USD | -538.833% |
| Dyne Therapeutics, Inc. | -233.47 Million USD | -193.094% |
| Kiniksa Pharmaceuticals, Ltd. | -22.85 Million USD | -2894.115% |
| Ventyx Biosciences, Inc. | -207.83 Million USD | -229.252% |
| Allakos Inc. | -189.91 Million USD | -260.322% |
| Imunon, Inc. | -19.87 Million USD | -3342.476% |
| Fulcrum Therapeutics, Inc. | -108.49 Million USD | -530.742% |
| Corcept Therapeutics Incorporated | 108.32 Million USD | 731.721% |
| BioAtla, Inc. | -122.24 Million USD | -459.8% |
| NLS Pharmaceutics AG | -11.79 Million USD | -5701.331% |
| Bio-Path Holdings, Inc. | -15.76 Million USD | -4241.761% |
| Allogene Therapeutics, Inc. | -300.29 Million USD | -127.879% |
| Larimar Therapeutics, Inc. | -41.44 Million USD | -1551.036% |
| XOMA Corporation | -39.36 Million USD | -1638.491% |
| Kezar Life Sciences, Inc. | -99.25 Million USD | -589.448% |
| Cara Therapeutics, Inc. | -117.65 Million USD | -481.645% |
| aTyr Pharma, Inc. | -52.17 Million USD | -1211.482% |
| Aligos Therapeutics, Inc. | -83.81 Million USD | -716.447% |
| Akero Therapeutics, Inc. | -148.63 Million USD | -360.405% |
| Viridian Therapeutics, Inc. | -234.56 Million USD | -191.734% |
| Eliem Therapeutics, Inc. | -13.65 Million USD | -4912.122% |
| EyeGate Pharmaceuticals, Inc. | -8.04 Million USD | -8408.822% |
| Akari Therapeutics, Plc | -16.8 Million USD | -3972.759% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 362730.229% |
| Halozyme Therapeutics, Inc. | 451.94 Million USD | 251.413% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -10611.303% |
| UroGen Pharma Ltd. | -63.83 Million USD | -972.057% |
| Sutro Biopharma, Inc. | -67.91 Million USD | -907.59% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -9321.78% |
| Orgenesis Inc. | -60.71 Million USD | -1027.022% |
| Entera Bio Ltd. | -8.8 Million USD | -7672.66% |
| GH Research PLC | -41.15 Million USD | -1562.831% |
| Lisata Therapeutics, Inc. | -25.51 Million USD | -2581.551% |
| Reneo Pharmaceuticals, Inc. | -82.23 Million USD | -732.154% |
| Xencor, Inc. | -125.87 Million USD | -443.643% |
| 60 Degrees Pharmaceuticals, Inc. | -1.42 Million USD | -47869.395% |
| Replimune Group, Inc. | -230.19 Million USD | -197.268% |
| Coeptis Therapeutics Holdings, Inc. | -20.15 Million USD | -3294.771% |
| Vanda Pharmaceuticals Inc. | -10.94 Million USD | -6153.93% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -10611.303% |
| Portage Biotech Inc. | -18.19 Million USD | -3660.124% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -44619.942% |
| Olema Pharmaceuticals, Inc. | -104.58 Million USD | -554.311% |
| OncoCyte Corporation | -23.12 Million USD | -2859.413% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -5955.602% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -5872.895% |
| Purple Biotech Ltd. | -22.22 Million USD | -2978.988% |
| CollPlant Biotechnologies Ltd. | -6.41 Million USD | -10575.585% |
| scPharmaceuticals Inc. | -46.06 Million USD | -1385.649% |
| ProMIS Neurosciences, Inc. | -17.8 Million USD | -3742.32% |
| HilleVax, Inc. | -132.46 Million USD | -416.589% |
| NeuroSense Therapeutics Ltd. | -10.63 Million USD | -6335.672% |
| Tharimmune, Inc. | -9.3 Million USD | -7256.07% |
| Genprex, Inc. | -31.06 Million USD | -2103.131% |
| Neumora Therapeutics, Inc. Common Stock | -187.52 Million USD | -264.912% |
| Atossa Therapeutics, Inc. | -31.35 Million USD | -2082.513% |
| XTL Biopharmaceuticals Ltd. | -764 Thousand USD | -89468.717% |
| Virios Therapeutics, Inc. | 150.9 Thousand USD | 453570.418% |
| OKYO Pharma Limited | -15.74 Thousand USD | -4345833.251% |
| Savara Inc. | -59.13 Million USD | -1057.23% |
| Curis, Inc. | -45.13 Million USD | -1415.995% |
| Daré Bioscience, Inc. | -30.7 Million USD | -2128.896% |
| Carmell Therapeutics Corporation | -15.19 Million USD | -4404.63% |
| Titan Pharmaceuticals, Inc. | -7.16 Million USD | -9450.663% |
| Achieve Life Sciences, Inc. | -26.73 Million USD | -2459.681% |
| BeiGene, Ltd. | -1.12 Billion USD | 39.152% |
| Kiromic BioPharma, Inc. | -16.3 Million USD | -4097.881% |
| Revolution Medicines, Inc. Warrant | -430.58 Million USD | -58.926% |
| Protagonist Therapeutics, Inc. | -90.34 Million USD | -657.477% |
| Erasca, Inc. | -121.31 Million USD | -464.096% |
| bluebird bio, Inc. | -167.16 Million USD | -309.369% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -15110.983% |
| BioMarin Pharmaceutical Inc. | 310.28 Million USD | 320.542% |
| DBV Technologies S.A. | -85.98 Million USD | -695.87% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -15110.983% |
| Moderna, Inc. | -3.28 Billion USD | 79.156% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -1506.01% |
| Fresh Tracks Therapeutics, Inc. | -5.64 Million USD | -12015.882% |
| Molecular Templates, Inc. | 1.43 Million USD | 47953.497% |
| Acrivon Therapeutics, Inc. Common Stock | -59.85 Million USD | -1043.329% |
| Travere Therapeutics, Inc. | -326.24 Million USD | -109.751% |
| Monte Rosa Therapeutics, Inc. | -137.08 Million USD | -399.168% |
| Spruce Biosciences, Inc. | -47.36 Million USD | -1344.718% |
| Celldex Therapeutics, Inc. | -139.03 Million USD | -392.185% |
| Cogent Biosciences, Inc. | -205.86 Million USD | -232.413% |
| MacroGenics, Inc. | 2.01 Million USD | 34026.872% |
| RenovoRx, Inc. | -11.39 Million USD | -5907.946% |
| Adicet Bio, Inc. | -136.53 Million USD | -401.194% |
| Prime Medicine, Inc. | -193.75 Million USD | -253.173% |
| Aditxt, Inc. | -25.45 Million USD | -2587.98% |
| Adagene Inc. | -14.95 Million USD | -4477.051% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -9261.092% |
| Quantum-Si incorporated | -91.8 Million USD | -645.398% |
| Maravai LifeSciences Holdings, Inc. | 712.4 Million USD | 196.055% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 126.45 Million USD | 641.145% |
| SciSparc Ltd. | -5.28 Million USD | -12855.415% |
| Vericel Corporation | 2.86 Million USD | 23993.331% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -718647.374% |
| Minerva Neurosciences, Inc. | -21.69 Million USD | -3054.725% |
| Generation Bio Co. | -133.3 Million USD | -413.357% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -724.166% |
| Black Diamond Therapeutics, Inc. | -86.02 Million USD | -695.491% |
| Arcutis Biotherapeutics, Inc. | -227.43 Million USD | -200.881% |
| Invivyd, Inc. | -196.61 Million USD | -248.043% |
| Relay Therapeutics, Inc. | -374.15 Million USD | -82.894% |
| Quoin Pharmaceuticals, Ltd. | -9.27 Million USD | -7278.112% |
| Spero Therapeutics, Inc. | 27.15 Million USD | 2620.089% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -6553.427% |
| 2seventy bio, Inc. | -206.41 Million USD | -231.514% |
| ADMA Biologics, Inc. | 5.12 Million USD | 13465.332% |
| Clene Inc. | -43.24 Million USD | -1482.537% |
| Capricor Therapeutics, Inc. | -23 Million USD | -2874.078% |
| Boundless Bio, Inc. Common Stock | -48.47 Million USD | -1311.608% |
| GeoVax Labs, Inc. | -26.66 Million USD | -2465.941% |
| Recursion Pharmaceuticals, Inc. | -299.56 Million USD | -128.432% |
| Citius Pharmaceuticals, Inc. | -36.72 Million USD | -1763.101% |
| Contineum Therapeutics, Inc. Class A Common Stock | 23.57 Million USD | 3002.919% |
| Relmada Therapeutics, Inc. | 4.91 Million USD | 14036.242% |
| Finch Therapeutics Group, Inc. | -32.48 Million USD | -2006.721% |
| ALX Oncology Holdings Inc. | -158.4 Million USD | -332.0% |
| Evaxion Biotech A/S | -21.4 Million USD | -3097.239% |
| Ocular Therapeutix, Inc. | -66.41 Million USD | -930.347% |
| Verve Therapeutics, Inc. | -217.66 Million USD | -214.379% |
| Trevena, Inc. | -35.28 Million USD | -1839.2% |
| Surrozen, Inc. | -41.13 Million USD | -1563.721% |
| Tyra Biosciences, Inc. | -79.59 Million USD | -759.766% |
| Cingulate Inc. | -22.95 Million USD | -2881.457% |
| Galmed Pharmaceuticals Ltd. | -7.46 Million USD | -9071.76% |
| Unity Biotechnology, Inc. | -37.28 Million USD | -1735.434% |
| Tenax Therapeutics, Inc. | -8.22 Million USD | -8218.431% |
| Terns Pharmaceuticals, Inc. | -102.26 Million USD | -569.142% |
| ACADIA Pharmaceuticals Inc. | -67.82 Million USD | -908.898% |
| Connect Biopharma Holdings Limited | -58.37 Million USD | -1072.317% |
| Clearmind Medicine Inc. | -8.71 Million USD | -7755.947% |
| Kronos Bio, Inc. | -121.83 Million USD | -461.688% |
| Bolt Biotherapeutics, Inc. | -74.34 Million USD | -820.482% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -27929.044% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -578.692% |
| Statera Biopharma, Inc. | 38.93 Million USD | 1857.56% |
| ImmunityBio, Inc. | -436.18 Million USD | -56.885% |
| Korro Bio, Inc. | -80.9 Million USD | -745.823% |
| Kineta, Inc. | -15.71 Million USD | -4254.747% |
| BioVie Inc. | -31.95 Million USD | -2041.786% |
| Codexis, Inc. | -49.28 Million USD | -1288.521% |
| Celularity Inc. | -183.94 Million USD | -272.014% |
| Crinetics Pharmaceuticals, Inc. | -221.51 Million USD | -208.927% |
| Celcuity Inc. | -58.3 Million USD | -1073.565% |
| Virax Biolabs Group Limited | -6.6 Million USD | -10253.913% |
| Cibus, Inc. | -314.58 Million USD | -117.526% |
| Eledon Pharmaceuticals, Inc. | - USD | Infinity% |
| eFFECTOR Therapeutics, Inc. | -33.73 Million USD | -1928.592% |
| IN8bio, Inc. | -28.5 Million USD | -2300.733% |
| Kodiak Sciences Inc. | -259.02 Million USD | -164.187% |
| Annexon, Inc. | -141.57 Million USD | -383.352% |
| Adverum Biotechnologies, Inc. | -112.59 Million USD | -507.736% |
| Assembly Biosciences, Inc. | -64.19 Million USD | -965.962% |
| Avalo Therapeutics, Inc. | -27.95 Million USD | -2347.881% |
| Ionis Pharmaceuticals, Inc. | -230.01 Million USD | -197.511% |
| Eyenovia, Inc. | -24.1 Million USD | -2738.729% |
| Puma Biotechnology, Inc. | 44.78 Million USD | 1628.012% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -211105.247% |
| Xilio Therapeutics, Inc. | -73.8 Million USD | -827.192% |
| Arcellx, Inc. | -64.14 Million USD | -966.81% |
| Cardiff Oncology, Inc. | -45.01 Million USD | -1420.205% |
| Enanta Pharmaceuticals, Inc. | -123.47 Million USD | -454.201% |
| Regulus Therapeutics Inc. | -30.88 Million USD | -2115.87% |
| Moolec Science SA | -52.07 Million USD | -1214.062% |
| Acumen Pharmaceuticals, Inc. | -51.6 Million USD | -1226.018% |
| Geron Corporation | -174.78 Million USD | -291.519% |
| LAVA Therapeutics N.V. | -40.41 Million USD | -1593.112% |
| Royalty Pharma plc | 1.88 Billion USD | 136.259% |
| Atea Pharmaceuticals, Inc. | -119.59 Million USD | -472.195% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -7238.979% |
| TFF Pharmaceuticals, Inc. | -20.74 Million USD | -3199.325% |
| Mersana Therapeutics, Inc. | -166.08 Million USD | -312.033% |
| Humacyte, Inc. | -96.45 Million USD | -609.433% |
| Structure Therapeutics Inc. | -102.45 Million USD | -567.882% |
| 89bio, Inc. | -134.46 Million USD | -408.917% |
| PMV Pharmaceuticals, Inc. | -78.87 Million USD | -767.582% |
| Avenue Therapeutics, Inc. | 4.05 Million USD | 16988.08% |
| Genelux Corporation | -24.16 Million USD | -2731.802% |
| Trevi Therapeutics, Inc. | -33.8 Million USD | -1924.571% |
| Lexicon Pharmaceuticals, Inc. | -163.46 Million USD | -318.627% |
| Notable Labs, Ltd. | -14.4 Million USD | -4652.118% |
| Liquidia Corporation | -70.05 Million USD | -876.867% |
| Mustang Bio, Inc. | -48.06 Million USD | -1323.767% |
| Immunovant, Inc. | -269.97 Million USD | -153.467% |
| Quantum-Si incorporated | -91.8 Million USD | -645.398% |
| Arbutus Biopharma Corporation | -70.98 Million USD | -864.0% |
| DiaMedica Therapeutics Inc. | -19.3 Million USD | -3444.153% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -570.808% |
| Acasti Pharma Inc. | -11.3 Million USD | -5955.261% |
| MiNK Therapeutics, Inc. | -22.25 Million USD | -2975.08% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -4363.565% |
| Xenon Pharmaceuticals Inc. | -210.51 Million USD | -225.065% |
| Elevai Labs, Inc. Common Stock | -4.27 Million USD | -15924.591% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -4209.225% |
| Tempest Therapeutics, Inc. | -28.77 Million USD | -2278.041% |
| Soleno Therapeutics, Inc. | -37.03 Million USD | -1747.975% |
| PepGen Inc. | -83.58 Million USD | -718.723% |
| Moleculin Biotech, Inc. | -29.5 Million USD | -2219.363% |
| United Therapeutics Corporation | 1.38 Billion USD | 149.344% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -2888.623% |
| Solid Biosciences Inc. | -93.43 Million USD | -632.394% |
| BriaCell Therapeutics Corp. | -4.77 Million USD | -14240.798% |
| Immuneering Corporation | -58.06 Million USD | -1078.601% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 21337954.693% |
| Silo Pharma, Inc. | -3.62 Million USD | -18771.059% |
| Belite Bio, Inc | -31.52 Million USD | -2070.399% |
| XOMA Corporation | -39.36 Million USD | -1638.491% |
| ARS Pharmaceuticals, Inc. | -67.44 Million USD | -914.582% |
| Bionomics Limited | -9.83 Million USD | -6856.444% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -714.794% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -1877.417% |
| uniQure N.V. | -253.1 Million USD | -170.369% |
| Cassava Sciences, Inc. | -95.68 Million USD | -615.149% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -9261.092% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -428.405% |
| Forte Biosciences, Inc. | -32.47 Million USD | -2007.045% |
| Anebulo Pharmaceuticals, Inc. | -8.05 Million USD | -8400.184% |
| Enlivex Therapeutics Ltd. | -28.21 Million USD | -2324.98% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -211105.247% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -6042.222% |
| FibroBiologics, Inc. Common Stock | -15.9 Million USD | -4203.534% |
| Altimmune, Inc. | -87.93 Million USD | -678.194% |
| Amicus Therapeutics, Inc. | -92.07 Million USD | -643.172% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -1877.417% |
| Compugen Ltd. | -12.51 Million USD | -5367.442% |
| Peak Bio, Inc. | -1356.23 USD | -50456312.26% |
| Zevra Therapeutics, Inc. | -48.59 Million USD | -1308.093% |
| Benitec Biopharma Inc. | -22.49 Million USD | -2942.708% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | -182.417% |
| NKGen Biotech, Inc. Common Stock | -28.54 Million USD | -2297.453% |
| Zura Bio Limited | -60.56 Million USD | -1029.906% |
| PolyPid Ltd. | -20.26 Million USD | -3277.116% |
| Aileron Therapeutics, Inc. | -15.61 Million USD | -4282.918% |
| NKGen Biotech, Inc. Warrants | -28.54 Million USD | -2297.453% |
| Instil Bio, Inc. | -146.12 Million USD | -368.311% |
| argenx SE | -216.02 Million USD | -216.774% |
| Immunome, Inc. | -28.27 Million USD | -2320.519% |
| Compass Therapeutics, Inc. | -48.47 Million USD | -1311.724% |
| Verona Pharma plc | -52.46 Million USD | -1204.243% |
| enGene Holdings Inc. Warrants | -94.77 Million USD | -622.054% |
| Shattuck Labs, Inc. | -87.61 Million USD | -681.036% |
| CervoMed Inc. | -2.17 Million USD | -31407.583% |
| LENZ Therapeutics, Inc. | -122.24 Million USD | -459.786% |
| Plus Therapeutics, Inc. | -12.69 Million USD | -5291.2% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -1320.486% |
| Moolec Science SA | -52.07 Million USD | -1214.062% |
| Enveric Biosciences, Inc. | -17.13 Million USD | -3892.448% |
| Inovio Pharmaceuticals, Inc. | -130.39 Million USD | -424.81% |
| AnaptysBio, Inc. | -143.16 Million USD | -377.987% |
| Design Therapeutics, Inc. | -66.32 Million USD | -931.745% |
| Leap Therapeutics, Inc. | -80.98 Million USD | -744.957% |
| NeurAxis, Inc. | -6.66 Million USD | -10167.92% |
| Seelos Therapeutics, Inc. | -37.75 Million USD | -1712.728% |
| Lumos Pharma, Inc. | -36.57 Million USD | -1771.22% |
| Achilles Therapeutics plc | -70.44 Million USD | -871.445% |
| enGene Holdings Inc. Common Stock | -94.77 Million USD | -622.054% |
| 180 Life Sciences Corp. | -22.13 Million USD | -2991.643% |
| Opiant Pharmaceuticals, Inc. | 5.82 Million USD | 11839.166% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -27929.044% |
| Nutriband Inc. | -5.12 Million USD | -13260.695% |
| ORIC Pharmaceuticals, Inc. | -109.74 Million USD | -523.524% |
| CG Oncology, Inc. Common stock | -55.43 Million USD | -1134.495% |
| Fractyl Health, Inc. Common Stock | -50.55 Million USD | -1253.719% |
| Rani Therapeutics Holdings, Inc. | -65.27 Million USD | -948.31% |
| MoonLake Immunotherapeutics | -54.1 Million USD | -1164.657% |
| Palisade Bio, Inc. | -12.28 Million USD | -5472.063% |
| Tourmaline Bio, Inc. | -45.37 Million USD | -1408.077% |
| Beam Therapeutics Inc. | -156.47 Million USD | -337.331% |
| Neurogene Inc. | -52.28 Million USD | -1208.773% |
| Mirum Pharmaceuticals, Inc. | -136.49 Million USD | -401.359% |
| AEON Biopharma, Inc. | -48.36 Million USD | -1314.993% |
| CARGO Therapeutics, Inc. Common Stock | -93.01 Million USD | -635.669% |
| Sesen Bio, Inc. | -50.84 Million USD | -1245.997% |
| Enliven Therapeutics, Inc. | -81.93 Million USD | -735.211% |
| Kiora Pharmaceuticals, Inc. | -12.35 Million USD | -5440.921% |
| Iovance Biotherapeutics, Inc. | -427.43 Million USD | -60.097% |
| Taysha Gene Therapies, Inc. | -105.19 Million USD | -550.499% |
| Athira Pharma, Inc. | -116.7 Million USD | -486.365% |
| Vaccinex, Inc. | -19.74 Million USD | -3365.186% |
| HCW Biologics Inc. | -23.57 Million USD | -2802.542% |
| XOMA Corporation | -39.36 Million USD | -1638.491% |
| Nektar Therapeutics | -243.1 Million USD | -181.483% |
| Arvinas, Inc. | -394.8 Million USD | -73.33% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 362730.229% |
| Merus N.V. | -149.2 Million USD | -358.628% |
| Omega Therapeutics, Inc. | -93.49 Million USD | -631.955% |
| Quince Therapeutics, Inc. | -31.26 Million USD | -2089.075% |
| Rezolute, Inc. | -68.42 Million USD | -900.11% |
| Clene Inc. | -43.24 Million USD | -1482.537% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -4337.145% |
| BeyondSpring Inc. | -21.54 Million USD | -3076.903% |
| Synlogic, Inc. | -55.16 Million USD | -1140.559% |
| Allarity Therapeutics, Inc. | -12.08 Million USD | -5563.37% |
| Phio Pharmaceuticals Corp. | -10.64 Million USD | -6330.229% |
| Peak Bio, Inc. | -1356.23 USD | -50456312.26% |
| Werewolf Therapeutics, Inc. | -32.46 Million USD | -2007.824% |
| Krystal Biotech, Inc. | 17.9 Million USD | 3922.079% |
| Karyopharm Therapeutics Inc. | -118.42 Million USD | -477.848% |
| SpringWorks Therapeutics, Inc. | -341.34 Million USD | -100.473% |
| Lipella Pharmaceuticals Inc. | -4.6 Million USD | -14755.424% |
| MannKind Corporation | 15.12 Million USD | 4623.134% |
| Ikena Oncology, Inc. | -74.39 Million USD | -819.802% |
| Cyclerion Therapeutics, Inc. | -12.59 Million USD | -5334.011% |
| Gyre Therapeutics, Inc. | 20.32 Million USD | 3466.483% |
| Gossamer Bio, Inc. | -172.15 Million USD | -297.5% |
| CohBar, Inc. | -12.06 Million USD | -5571.463% |
| Cognition Therapeutics, Inc. | -25.5 Million USD | -2582.602% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -2179.117% |
| Legend Biotech Corporation | -477.87 Million USD | -43.198% |
| Mural Oncology plc | -192.72 Million USD | -255.077% |
| Biora Therapeutics, Inc. | -114.05 Million USD | -499.983% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -4138.424% |
| Disc Medicine, Inc. | -91.02 Million USD | -651.777% |
| Champions Oncology, Inc. | -5.05 Million USD | -13439.869% |
| REGENXBIO Inc. | -239.46 Million USD | -185.765% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -6284.522% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -1127.321% |
| Cellectar Biosciences, Inc. | -38.76 Million USD | -1665.116% |
| Edgewise Therapeutics, Inc. | -112.8 Million USD | -506.621% |
| Vaxart, Inc. | -74.72 Million USD | -815.789% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -35.2 Million USD | -1843.59% |
| Cellectis S.A. | -98.09 Million USD | -597.594% |
| Longeveron Inc. | -20.06 Million USD | -3311.291% |
| Repare Therapeutics Inc. | -114.27 Million USD | -498.833% |
| Sarepta Therapeutics, Inc. | -439.19 Million USD | -55.809% |
| Inozyme Pharma, Inc. | -74.81 Million USD | -814.7% |
| Revolution Medicines, Inc. | -430.58 Million USD | -58.926% |
| Nymox Pharmaceutical Corporation | -6.28 Million USD | -10780.983% |
| Third Harmonic Bio, Inc. | -30.78 Million USD | -2122.563% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -817.422% |
| AN2 Therapeutics, Inc. | 4.9 Million USD | 14056.863% |
| Anixa Biosciences, Inc. | -10.96 Million USD | -6140.812% |
| Vertex Pharmaceuticals Incorporated | 4.6 Billion USD | 114.859% |
| Denali Therapeutics Inc. | -179.97 Million USD | -280.226% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -718647.374% |
| Veru Inc. | -89.97 Million USD | -660.545% |
| Corvus Pharmaceuticals, Inc. | -26.87 Million USD | -2445.967% |
| Cingulate Inc. | -22.95 Million USD | -2881.457% |
| Passage Bio, Inc. | -98.34 Million USD | -595.849% |
| Context Therapeutics Inc. | -25.06 Million USD | -2630.604% |
| Exicure, Inc. | -15.53 Million USD | -4303.79% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | -232.084% |
| Oramed Pharmaceuticals Inc. | -36.97 Million USD | -1750.673% |
| Scinai Immunotherapeutics Ltd. | -5.96 Million USD | -11376.629% |
| Rhythm Pharmaceuticals, Inc. | -168.46 Million USD | -306.203% |
| Nuvalent, Inc. | -149.49 Million USD | -357.754% |
| ABVC BioPharma, Inc. | -8.13 Million USD | -8314.536% |
| Carisma Therapeutics, Inc. | -85.89 Million USD | -696.685% |
| Unicycive Therapeutics, Inc. | -30.17 Million USD | -2167.562% |
| OmniAb, Inc. | -49.73 Million USD | -1276.013% |
| Anew Medical, Inc. | -1.3 Million USD | -52504.855% |
| Fennec Pharmaceuticals Inc. | -12.36 Million USD | -5434.657% |
| Lipocine Inc. | -16.32 Million USD | -4092.36% |
| Lexeo Therapeutics, Inc. Common Stock | -66.67 Million USD | -926.406% |
| Nautilus Biotechnology, Inc. | -74.3 Million USD | -820.966% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -1694.511% |
| G1 Therapeutics, Inc. | -39.01 Million USD | -1653.999% |
| Bellerophon Therapeutics, Inc. | -22.18 Million USD | -2984.817% |
| Sage Therapeutics, Inc. | -545.07 Million USD | -25.544% |
| Ocugen, Inc. | -64.82 Million USD | -955.586% |
| Mind Medicine (MindMed) Inc. | -92.57 Million USD | -639.23% |
| Q32 Bio Inc. | -86.5 Million USD | -691.086% |
| Brainstorm Cell Therapeutics Inc. | -16.92 Million USD | -3942.683% |
| Alumis Inc. Common Stock | -156.89 Million USD | -336.169% |
| Equillium, Inc. | -12.13 Million USD | -5537.708% |
| Kyverna Therapeutics, Inc. | -58.47 Million USD | -1070.312% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -8558.418% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -3528.153% |
| Galera Therapeutics, Inc. | -46.69 Million USD | -1365.572% |
| Evelo Biosciences, Inc. | -106.34 Million USD | -543.476% |
| Comera Life Sciences Holdings, Inc. | -17.88 Million USD | -3725.799% |
| Dominari Holdings Inc. | -22.44 Million USD | -2949.488% |
| Edesa Biotech, Inc. | -8.19 Million USD | -8255.228% |
| vTv Therapeutics Inc. | -25.41 Million USD | -2592.842% |
| Bio-Techne Corporation | 326.66 Million USD | 309.483% |
| Agios Pharmaceuticals, Inc. | -384.86 Million USD | -77.804% |
| Harmony Biosciences Holdings, Inc. | 216.38 Million USD | 416.238% |
| Prelude Therapeutics Incorporated | -131.1 Million USD | -421.94% |
| Candel Therapeutics, Inc. | -37.43 Million USD | -1728.177% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -352.879% |
| Nkarta, Inc. | -120.48 Million USD | -467.978% |
| BioCardia, Inc. | -11.56 Million USD | -5819.593% |
| Iterum Therapeutics plc | -34.58 Million USD | -1878.904% |